Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Liabilities and Shareholders Equity (2017 - 2026)

Inspire Medical Systems' Liabilities and Shareholders Equity history spans 10 years, with the latest figure at $911.4 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 24.71% to $911.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.4 billion, a 11.91% increase, with the full-year FY2025 number at $907.3 million, up 12.24% from a year prior.
  • Liabilities and Shareholders Equity hit $911.4 million in Q1 2026 for Inspire Medical Systems, roughly flat from $907.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for INSP hit a ceiling of $911.4 million in Q1 2026 and a floor of $289.7 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $668.2 million across 5 years, with a median of $685.8 million in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 111.73% in 2023 and later grew 1.45% in 2025.
  • Tracing INSP's Liabilities and Shareholders Equity over 5 years: stood at $564.9 million in 2022, then increased by 19.82% to $676.8 million in 2023, then grew by 19.44% to $808.4 million in 2024, then grew by 12.24% to $907.3 million in 2025, then rose by 0.45% to $911.4 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for INSP at $911.4 million in Q1 2026, $907.3 million in Q4 2025, and $807.7 million in Q3 2025.